1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. World Health Organization Classification of Tumours: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn. International Agency for Research on Cancer: Lyon, 2008.
2. Adolfsson J, Mansson R, Buza-Vidas N, Hultquist A, Liuba K, Jensen CT et al. Identification of Alt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment. Cell 2005; 121: 295–306.
3. Hirata J, Sato H, Takahira H, Shiokawa S, Endo T, Nishimura J et al. A novel CD10-positive erythroid cell line, RM10, established from a patient with chronic myelogenous leukemia. Leukemia 1990; 4: 365–372.
4. Takahashi M, Shigeno N, Takahashi H, Suzuki N, Masuko M, Nikkuni K et al. Effects of transfection of p210bcr-abl and bcr-v-abl into the factor-dependent human leukemia cell line HSM-911. Leuk Res 1997; 21: 1115–1123.
5. Williams L, Moscinski LC . Sterile transcription of immunoglobulin/T-cell receptor genes and other evidence of early lymphoid differentiation in acute myelogenous leukemia. Leukemia 1993; 7: 1423–1431.